Pages that link to "Q54996405"
Jump to navigation
Jump to search
The following pages link to Evidence of altered phosphatidylcholine metabolism in Alzheimer's disease. (Q54996405):
Displaying 50 items.
- Nutritional Factors Affecting Mental Health (Q26740031) (← links)
- Blood-Based Proteomic Biomarkers of Alzheimer's Disease Pathology (Q26774743) (← links)
- A Review on Potential Mechanisms of Terminalia chebula in Alzheimer's Disease (Q26864964) (← links)
- Loss of Ypk1, the yeast homolog to the human serum- and glucocorticoid-induced protein kinase, accelerates phospholipase B1-mediated phosphatidylcholine deacylation (Q27930785) (← links)
- APOE ε4 specific imbalance of arachidonic acid and docosahexaenoic acid in serum phospholipids identifies individuals with preclinical Mild Cognitive Impairment/Alzheimer's Disease. (Q33563660) (← links)
- Cerebrospinal fluid metabolomics reveals altered waste clearance and accelerated aging in HIV patients with neurocognitive impairment (Q33863368) (← links)
- PLD1 promotes dendritic spine development by inhibiting ADAM10-mediated N-cadherin cleavage (Q33920841) (← links)
- Aging-related Changes in Mouse Serum Glycerophospholipid Profiles (Q34800397) (← links)
- Plasma lipidomics analysis finds long chain cholesteryl esters to be associated with Alzheimer's disease (Q35034769) (← links)
- Metabolomic method: UPLC-q-ToF polar and non-polar metabolites in the healthy rat cerebellum using an in-vial dual extraction (Q35325389) (← links)
- Mass Spectrometry-based Lipidomics and Its Application to Biomedical Research (Q35332947) (← links)
- The promise of metabolic phenotyping in gastroenterology and hepatology (Q35701279) (← links)
- Plasma 24-metabolite Panel Predicts Preclinical Transition to Clinical Stages of Alzheimer's Disease (Q36272443) (← links)
- Association between fatty acid metabolism in the brain and Alzheimer disease neuropathology and cognitive performance: A nontargeted metabolomic study (Q36316280) (← links)
- The ratio of phosphatidylcholines to lysophosphatidylcholines in plasma differentiates healthy controls from patients with Alzheimer's disease and mild cognitive impairment (Q36428387) (← links)
- ABCA1-Mediated Cholesterol Efflux Capacity to Cerebrospinal Fluid Is Reduced in Patients With Mild Cognitive Impairment and Alzheimer's Disease. (Q36713957) (← links)
- Omega-3 Fatty Acid Status Enhances the Prevention of Cognitive Decline by B Vitamins in Mild Cognitive Impairment (Q37053948) (← links)
- Blood metabolite markers of cognitive performance and brain function in aging (Q37057711) (← links)
- Plasma Phospholipid and Sphingolipid Alterations in Presenilin1 Mutation Carriers: A Pilot Study (Q37091714) (← links)
- Blood metabolite markers of preclinical Alzheimer's disease in two longitudinally followed cohorts of older individuals (Q37100094) (← links)
- European multicentre double-blind placebo-controlled trial of Nilvadipine in mild-to-moderate Alzheimer's disease-the substudy protocols: NILVAD frailty; NILVAD blood and genetic biomarkers; NILVAD cerebrospinal fluid biomarkers; NILVAD cerebral blo (Q37133760) (← links)
- Inferior Prefrontal Cortex Mediates the Relationship between Phosphatidylcholine and Executive Functions in Healthy, Older Adults (Q37292322) (← links)
- Potential fluid biomarkers for pathological brain changes in Alzheimer's disease: Implication for the screening of cognitive frailty (Q37297626) (← links)
- Blood metabolite markers of neocortical amyloid-β burden: discovery and enrichment using candidate proteins (Q37347834) (← links)
- BACE1 RNAi Restores the Composition of Phosphatidylethanolamine-Derivates Related to Memory Improvement in Aged 3xTg-AD Mice (Q37409066) (← links)
- Prospective associations of plasma phospholipids and mild cognitive impairment/dementia among African Americans in the ARIC Neurocognitive Study (Q37543795) (← links)
- The Role of PICALM in Alzheimer's Disease (Q38245888) (← links)
- Deciphering non-alcoholic fatty liver disease through metabolomics. (Q38252319) (← links)
- Clearing the amyloid in Alzheimer's: progress towards earlier diagnosis and effective treatments - an update for clinicians. (Q38269095) (← links)
- Advances in clinical determinants and neurological manifestations of B vitamin deficiency in adults (Q38795338) (← links)
- Metabolic network failures in Alzheimer's disease: A biochemical road map. (Q38877855) (← links)
- Lipid (per) oxidation in mitochondria: an emerging target in the ageing process? (Q39328053) (← links)
- Characterizing Alzheimer's disease through metabolomics and investigating anti-Alzheimer's disease effects of natural products (Q39386254) (← links)
- Association between Plasma Ceramides and Phosphatidylcholines and Hippocampal Brain Volume in Late Onset Alzheimer's Disease (Q40444820) (← links)
- Metabolomics and cognition in African American adults in midlife: the atherosclerosis risk in communities study (Q41196957) (← links)
- Neuroprotective Actions of Dietary Choline. (Q41583852) (← links)
- Alzheimer's brains show inter-related changes in RNA and lipid metabolism (Q41654331) (← links)
- Targeted metabolomic profiling indicates structure-based perturbations in serum phospholipids in children with acetaminophen overdose (Q41679331) (← links)
- Metabolic status of CSF distinguishes rats with tauopathy from controls. (Q41690749) (← links)
- Early Effect of Amyloid β-Peptide on Hippocampal and Serum Metabolism in Rats Studied by an Integrated Method of NMR-Based Metabolomics and ANOVA-Simultaneous Component Analysis. (Q42323524) (← links)
- Lower brain and blood nutrient status in Alzheimer's disease: Results from meta-analyses (Q42655692) (← links)
- Metabolic phenotyping in the mouse model of urinary tract infection shows that 3-hydroxybutyrate in plasma is associated with infection (Q42696026) (← links)
- The role of mitochondrial dysfunction in the progression of Alzheimer's disease. (Q46349473) (← links)
- Systems healthcare: a holistic paradigm for tomorrow (Q47281739) (← links)
- Differential Pattern of Phospholipid Profile in the Temporal Cortex from E280A-Familiar and Sporadic Alzheimer's Disease Brains (Q47361754) (← links)
- Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study. (Q47549112) (← links)
- Application of Metabolomics in Alzheimer's Disease (Q49464422) (← links)
- Plasma lipids metabolism in mild cognitive impairment and Alzheimer's disease (Q50041775) (← links)
- Pramlintide: The Effects of a Single Drug Injection on Blood Phosphatidylcholine Profile for Alzheimer's Disease. (Q51246561) (← links)
- A Decade of Blood Biomarkers for Alzheimer's Disease Research: An Evolving Field, Improving Study Designs, and the Challenge of Replication (Q51760901) (← links)